Literature DB >> 9363893

The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth.

M Nguyen1, T Camenisch, J N Snouwaert, E Hicks, T M Coffman, P A Anderson, N N Malouf, B H Koller.   

Abstract

Survival of newborn placental mammals depends on closure of the ductus arteriosus (DA), an arterial connection in the fetus which directs blood away from the pulmonary circulation and towards the placenta where oxygenation occurs. Here we show that morphological changes resulting in closure of the DA in mice are virtually identical to those observed in larger mammals, including humans, and that maintenance of the DA in the open, or patent, state in fetal mice is dependent on prostaglandin synthesis. This requirement is absent in mice lacking the prostaglandin E2 EP4 receptor (EP4(-/-) mice). In EP4(-/-) mice of the 129 strain, remodelling of the DA fails to occur after birth, resulting in a left-to-right shunt of blood and subsequently in death. This suggests that the neonatal drop in prostaglandin E2 that triggers ductal closure is sensed through the EP4 receptor. In contrast, 5% of EP4(-/-) mice of mixed genetic background survive, and selective breeding of these mice leads to a 21% survival rate, suggesting that alleles at other loci can provide an alternative mechanism for ductal closure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9363893     DOI: 10.1038/36342

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  94 in total

Review 1.  Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes.

Authors:  S L Tilley; T M Coffman; B H Koller
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

Review 2.  Genetic and pharmacological analysis of prostanoid receptor function.

Authors:  S Narumiya; G A FitzGerald
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

3.  Not a mouse stirring: deletion of the EP2 and love's labor's lost.

Authors:  S Austin; G A FitzGerald
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

4.  Finding genetic contributions to sporadic disease: a recessive locus at 12q24 commonly contributes to patent ductus arteriosus.

Authors:  Arya Mani; Seyed-Mahmoud Meraji; Roozbeh Houshyar; Jayaram Radhakrishnan; Alaleh Mani; Mehrabeh Ahangar; Tayebeh M Rezaie; Mohammad-Ali Taghavinejad; Behrooz Broumand; Hongyu Zhao; Carol Nelson-Williams; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-30       Impact factor: 11.205

Review 5.  Targeting rheumatoid inflammation and joint destruction in the mouse.

Authors:  Masaki Inada; Stephen M Krane
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

6.  Identification of a region of the C-terminal domain involved in short-term desensitization of the prostaglandin EP4 receptor.

Authors:  M Bastepe; B Ashby
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

7.  A major role for the EP4 receptor in regulation of renin.

Authors:  Carie S Facemire; Mytrang Nguyen; Leigh Jania; William H Beierwaltes; Hyung-Suk Kim; Beverly H Koller; Thomas M Coffman
Journal:  Am J Physiol Renal Physiol       Date:  2011-08-10

8.  GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.

Authors:  Zoltán Benyó; Andreas Gille; Jukka Kero; Marion Csiky; Marie Catherine Suchánková; Rolf M Nüsing; Alexandra Moers; Klaus Pfeffer; Stefan Offermanns
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

9.  Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse.

Authors:  C Nataraj; D W Thomas; S L Tilley; M T Nguyen; R Mannon; B H Koller; T M Coffman
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

10.  Failure of postnatal ductus arteriosus closure in prostaglandin transporter-deficient mice.

Authors:  Hee-Yoon Chang; Joseph Locker; Run Lu; Victor L Schuster
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.